Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(3.40) per share which missed the analyst consensus estimate of $(0.21) by 1481.4 percent. This is a 900 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $26.334 million which missed the analyst consensus estimate of $26.625 million by 1.09 percent. This is a 21.51 percent increase over sales of $21.672 million the same period last year.